Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
Cassuto E, Pageaux GP, Cantarovich D, Rostaing L, Loupy A, Roche B, Duvoux C, Moreau K, Thervet E, Mazouz H, Bourhis Y, Dharancy S, Kessler M; OSIRIS investigators. Cassuto E, et al. Among authors: dharancy s. Transplantation. 2016 Oct;100(10):2099-2106. doi: 10.1097/TP.0000000000001307. Transplantation. 2016. PMID: 27653227
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Decaens T, et al. Among authors: dharancy s. Liver Transpl. 2005 Jul;11(7):767-775. doi: 10.1002/lt.20418. Liver Transpl. 2005. PMID: 15973710 Free article.
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C. Decaens T, et al. Among authors: dharancy s. Liver Transpl. 2006 Dec;12(12):1761-9. doi: 10.1002/lt.20884. Liver Transpl. 2006. PMID: 16964590 Free article.
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Decaens T, et al. Among authors: dharancy s. World J Gastroenterol. 2006 Dec 7;12(45):7319-25. doi: 10.3748/wjg.v12.i45.7319. World J Gastroenterol. 2006. PMID: 17143948 Free PMC article.
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Vanlemmens C, Meyer C, Gugenheim J, Durand F, Boillot O, Declerck N, Louvet A, Canva V, Romano O, Ernst O, Mathurin P, Pruvot FR. Dharancy S, et al. Liver Transpl. 2007 May;13(5):665-71. doi: 10.1002/lt.21109. Liver Transpl. 2007. PMID: 17427172 Free article. Clinical Trial.
Impact of impaired aerobic capacity on liver transplant candidates.
Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V, Wallaert B, Mathurin P, Pruvot FR. Dharancy S, et al. Transplantation. 2008 Oct 27;86(8):1077-83. doi: 10.1097/TP.0b013e318187758b. Transplantation. 2008. PMID: 18946345
Inhibitory effects of cyclosporine on human regulatory T cells in vitro.
Miroux C, Moralès O, Carpentier A, Dharancy S, Conti F, Boleslowski E, Podevin P, Auriault C, Pancré V, Delhem N. Miroux C, et al. Among authors: dharancy s. Transplant Proc. 2009 Oct;41(8):3371-4. doi: 10.1016/j.transproceed.2009.08.043. Transplant Proc. 2009. PMID: 19857752
219 results